A new FDA-approved drug brings in a lot of hope for men with aggressive prostate cancer, as it may increase their chances of survival by 40 per cent. According to experts, the combination of two drugs ...
New research in the July 2025 issue of JNCCN-Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate cancer later in life, and treated ...
News-Medical.Net on MSN
New trial aims to improve both survival and quality of life for men with advanced prostate cancer
The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback